Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Hantech Bio-Technology Co's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hantech Bio-Technology Co Buyback Yield % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Hantech Bio-Technology Co's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Hantech Bio-Technology Co's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hantech Bio-Technology Co (ROCO:1294) has a Buyback Yield % of 0.61 as of Aug. 06, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Hantech Bio-Technology Co and its competitors. According to the industry distribution chart, Hantech Bio-Technology Co ranks #163 out of 548 companies in the Consumer Packaged Goods industry, placing it in the top 29.7%.
Is Hantech Bio-Technology Co's Buyback Yield % too high?
Hantech Bio-Technology Co's current Buyback Yield % is 0.61. Based on the distribution chart, Hantech Bio-Technology Co ranks #163 out of 548 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Hantech Bio-Technology Co has a GF Score™ of 75/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hantech Bio-Technology Co's Buyback Yield % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Hantech Bio-Technology Co ranks #163 out of 548 companies for Buyback Yield %. This puts Hantech Bio-Technology Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Consumer Packaged Goods company?
A good Buyback Yield % depends on the Consumer Packaged Goods industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Hantech Bio-Technology Co and its competitors. Hantech Bio-Technology Co's current Buyback Yield % is 0.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hantech Bio-Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Hantech Bio-Technology Co (ROCO:1294) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$79.97, compared to a current price of NT$56.20 — trading 29.7% below its estimated fair value. The current Buyback Yield % is 0.61. Hantech Bio-Technology Co's overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Hantech Bio-Technology Co (ROCO:1294), the current Buyback Yield % is 0.61 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hantech Bio-Technology Co (ROCO:1294) Overvalued in 2026?
Based on GuruFocus' analysis, Hantech Bio-Technology Co stock appears to be undervalued.
The current stock price of NT$56.20 is trading 29.7% below its estimated GF Value™ of NT$79.97.
GuruFocus considers Hantech Bio-Technology Co to be Significantly Undervalued.
Key valuation signals for ROCO:1294:
Buyback Yield %: 0.61
GF Value™: NT$79.97 vs. price of NT$56.20 (29.7% below fair value)
No single metric tells the full story. See the ROCO:1294 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hantech Bio-Technology Co Ltd mainly engaged in the manufacture, trading, and agency of biotech foods, health foods, and Traditional Chinese Medicine skincare and beauty products.
75GF Score
Get the complete analysis for ROCO:1294
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:1294 has been successfully added to your 
